Facebook Linkedin Mail X Youtube
Facebook Linkedin Mail X Youtube

Search

Highlights
Short cuts

“No clear explanation why the findings of SWEDEPAD 2 are given greater methodological weight than extensive body of randomised evidence”

Watch Now
In conversation

Drug-coated technology in PAD: The ESVS guidelines edition, part two

Watch Now
Short cuts

“We were disappointed both in not finding a clinical efficacy and finding the mortality signal”

Watch Now
In conversation

Drug-coated technology in PAD: The ESVS guidelines edition, part one

Watch Now
In Focus

Where vascular surgery meets space medicine

Watch Now

In focus

In Focus

Where vascular surgery meets space medicine

30 September 2026
SPONSORED In Focus

Reduced noise, increased visibility: OPTIQ AI leads to “easier and more reliable” procedures

16 September 2026
In Focus

Acute limb ischaemia study: 90-day outcome metrics “were largely the same, if not better, for endovascular-first approaches”

10 September 2026
In Focus

Elegant solution to a longstanding problem: how a simple endograft explant innovation could circumvent a thorny problem in vascular care

1 September 2026
SPONSORED In Focus

“A real gamechanger”: experts describe early experience with Allia Moveo imaging system

25 August 2026
SPONSORED In Focus

Shockwave IVL “no longer a niche adjunct” for calcified iliac disease treatment

12 August 2026
In Focus

Prediction, mitigation, adaptation: Researchers tackle live issue of vascular surgeon burnout

3 August 2026
In Focus

AxSESing small anatomy: a pitch for ultra-low profile, upper extremity AAA access

24 July 2026

In conversation

In conversation

Drug-coated technology in PAD: The ESVS guidelines edition, part two

5 October 2026
In conversation

Drug-coated technology in PAD: The ESVS guidelines edition, part one

4 October 2026
SPONSORED In conversation

How three-year data from SIRONA trial showing superiority of sirolimus-coated balloon could change PAD treatment

10 August 2026
In conversation

Unpacking CREST-2, part two: “It’s a public health benefit to revascularize patients based on CREST-2”

7 August 2026
In conversation

Unpacking CREST-2, part one: “Which patient should be treated with which therapy?”

3 August 2026
SPONSORED In conversation

“Something we’ve never seen before”: How PGG could redefine treatment for small- to mid-sized AAAs

24 July 2026
In conversation

Robotic vascular surgery: Pushing the boundaries of the endovascular revolution

9 July 2026
SPONSORED In conversation

“Unique” SirPAD trial demonstrates superiority of sirolimus-coated balloon in all-comer population

1 July 2026

Webinars

Webinars

Vascular News Live: Aortic Roundtable Discussion

25 March 2025
Webinars

Vascular News Live: Pressing challenges and hot topics in vascular access

13 March 2025
Webinars

Vascular News Live: Pressing challenges and hot topics in CLTI and PAD

7 March 2025
SPONSORED Webinars

GORE® ACTIVE CONTROL System: “A system for the masses”

11 May 2021
SPONSORED Webinars

WavelinQ™ 4F EndoAVF System – An attractive non-surgical AV fistula option for dialysis patients

18 December 2020
SPONSORED Webinars

Webinar: Safety of paclitaxel devices—What does the evidence say?

2 August 2019

Short cuts

Short cuts

“No clear explanation why the findings of SWEDEPAD 2 are given greater methodological weight than extensive body of randomised evidence”

5 October 2026
Short cuts

“We were disappointed both in not finding a clinical efficacy and finding the mortality signal”

4 October 2026
Short cuts

“It tracks our learning curve as we transitioned from largely open first to almost exclusively endovascular first”

10 September 2026
Short cuts

“We have a lot of data, a lot of trials, in the last 15 years supporting the use of drug-coated devices”

9 September 2026
Short cuts

“There really is nothing else like this”

1 September 2026
Short cuts

“I don’t think we’re going to see another CREST-3”

7 August 2026
Short cuts

“Don’t look at absolute event rates and absolute reductions—look at the proportion of reductions”

4 August 2026
Short cuts

Levels of burnout among vascular trainees track that among surgeons—but latest data also show it is “modifiable”

3 August 2026
Vascular News

Write to us
Editor: Jocelyn Hudson jocelyn@bibamedical.com
Advertising: Nathalie Fortin nathalie@bibamedical.com


BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy
Facebook Linkedin Mail X Youtube